Obesity Patterns, Metabolic Abnormality, and Diabetic Kidney Disease in Patients with Type 2 Diabetes

References

• International Diabetes Federation. IDF diabetes atlas, 10th edition. Brussels; 2021. Available from: http://www.diabetesatlas.org/. Accessed April 11, 2022.
   Google Scholar
• American Diabetes Association. 11. Microvascular complications and foot care: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(suppl1):S135–S151 . doi:10.2337/dc20-S011
   PubMedGoogle Scholar
• Bikbov B, Purcell CA, Levey AS, GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-3
   PubMed Web of Science ®Google Scholar
• Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37(10):2864–2883. doi:10.2337/dc14-1296
   PubMed Web of Science ®Google Scholar
• Vazquez G, Duval S, Jacobs DR, et al. Comparison of body mass index, waist circumference, and waist/Hip ratio in predicting incident diabetes: a meta-analysis. Epidemiol Rev. 2007;29(1):115–128. doi:10.1093/epirev/mxm008
   PubMed Web of Science ®Google Scholar
• Guh DP, Zhang W, Bansback N, et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9(1):88. doi:10.1186/1471-2458-9-88
   PubMed Web of Science ®Google Scholar
• Chang AR, Grams ME, Ballew SH, et al. Adiposity and risk of decline in glomerular filtration rate: meta-analysis of individual participant data in a global consortium. BMJ. 2019;364(k 5301). doi:10.1136/bmj.k5301
   PubMedGoogle Scholar
• Xia Y, Jiang C, Lu J, et al. Associations between obesity and kidney disease in Chinese men and women with type 2 diabetes: a retrospective cohort study. Can J Diabetes. 2022;46(1):47–52.e3. doi:10.1016/j.jcjd.2021.05.005
   PubMed Web of Science ®Google Scholar
• Man REK, Gan ATL, Fenwick EK, et al. The relationship between generalized and abdominal obesity with diabetic kidney disease in type 2 diabetes: a multiethnic Asian study and meta-analysis. Nutrients. 2018;10(11):1685. doi:10.3390/nu10111685
   PubMed Web of Science ®Google Scholar
• Hu J, Yang S, Zhang A, et al. Abdominal obesity is more closely associated with diabetic kidney disease than general obesity. Diabetes Care. 2016;39(10):e179–e180. doi:10.2337/dc16-1025
   PubMed Web of Science ®Google Scholar
• Luk AO, So WY, Ma RC, et al. Metabolic syndrome predicts new onset of chronic kidney disease in 5829 patients with type 2 diabetes: a 5-year prospective analysis of the Hong Kong Diabetes Registry. Diabetes Care. 2008;31(12):2357–2361. doi:10.2337/dc08-0971
   PubMed Web of Science ®Google Scholar
• Huang WH, Chen CY, Lin JL, et al. High body mass index reduces glomerular filtration rate decline in type II diabetes mellitus patients with stage 3 or 4 chronic kidney disease. Medicine. 2014;93(7):e41. doi:10.1097/MD.0000000000000041
   PubMed Web of Science ®Google Scholar
• Lu Y, Hajifathalian K, Ezzati M, et al. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet. 2014;383:9921):970–983.
   Web of Science ®Google Scholar
• Kramer CK, Zinman B, Retnakaran R. Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis. Ann Intern Med. 2013;159(11):758–769. doi:10.7326/0003-4819-159-11-201312030-00008
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of incident CKD. Clin J Am Soc Nephrol. 2015;10(4):578–583. doi:10.2215/CJN.08980914
   PubMed Web of Science ®Google Scholar
• Lin L, Peng K, Du R, et al. Metabolically healthy obesity and incident chronic kidney disease: the role of systemic inflammation in a prospective study. Obesity. 2017;25(3):634–641. doi:10.1002/oby.21768
   PubMed Web of Science ®Google Scholar
• Chang Y, Ryu S, Choi Y, et al. Metabolically healthy obesity and development of chronic kidney disease: a cohort study. Ann Intern Med. 2016;164(5):305–312. doi:10.7326/M15-1323
   PubMed Web of Science ®Google Scholar
• Nam KH, Yun HR, Joo YS, et al. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease. Diabetes Obes Metab. 2018;20(12):2778–2791. doi:10.1111/dom.13458
   PubMed Web of Science ®Google Scholar
• Wang J, Niratharakumar K, Gokhale K, et al. Obesity without metabolic abnormality and incident CKD: a population-based British cohort study. Am J Kidney Dis. 2022;79(1):24–35.e1. doi:10.1053/j.ajkd.2021.05.008
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang W, Wang Y, et al. Novel associations between sex hormones and diabetic vascular complications in men and postmenopausal women: a cross-sectional study. Cardiovasc Diabetol. 2019;18(1):97. doi:10.1186/s12933-019-0901-6
   PubMedGoogle Scholar
• Wang B, Wan H, Cheng J, et al. Blood lead, vitamin D status, and albuminuria in patients with type 2 diabetes. Environ Pollut. 2021;276:116653. doi:10.1016/j.envpol.2021.116653
   PubMed Web of Science ®Google Scholar
• Chen C, Lu FC. Department of Disease Control Ministry of Health, PR China. The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed Environ Sci. 2004;17(Suppl):1–36.
   PubMedGoogle Scholar
• World Health Organization. Waist Circumference and Waist-Hip Ratio. Report of a WHO Expert Consultation. Geneva: World Health Organization; 2011.
   Google Scholar
• National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143–3421.
   PubMed Web of Science ®Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3(1):21. doi:10.1186/1471-2288-3-21
   PubMedGoogle Scholar
• Garofalo C, Borrelli S, Minutolo R, et al. A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population. Kidney Int. 2017;91(5):1224–1235. doi:10.1016/j.kint.2016.12.013
   PubMed Web of Science ®Google Scholar
• Chung HF, Al Mamun A, Huang MC, et al. Obesity, weight change, and chronic kidney disease in patients with type 2 diabetes mellitus: a longitudinal study in Taiwan. J Diabet. 2017;9(11):983–993. doi:10.1111/1753-0407.12514
   PubMed Web of Science ®Google Scholar
• Ou YL, Lee MY, Lin IT, et al. Obesity-related indices are associated with albuminuria and advanced kidney disease in type 2 diabetes mellitus. Ren Fail. 2021;43(1):1250–1258. doi:10.1080/0886022X.2021.1969247
   PubMed Web of Science ®Google Scholar
• Janssen I, Katzmarzyk PT, Ross R. Waist circumference and not body mass index explains obesity-related health risk. Am J Clin Nutr. 2004;79(3):379–384. doi:10.1093/ajcn/79.3.379
   PubMed Web of Science ®Google Scholar
• Yusuf S, Hawken S, Ounpuu S, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet. 2005;366(9497):1640–1649. doi:10.1016/S0140-6736(05)67663-5
   PubMed Web of Science ®Google Scholar
• Zhang J, Jiang H, Chen J. Combined effect of body mass index and metabolic status on the risk of prevalent and incident chronic kidney disease: a systematic review and meta-analysis. Oncotarget. 2017;8(22):35619–35629. doi:10.18632/oncotarget.10915
   PubMedGoogle Scholar
• Thomas G, Sehgal AR, Kashyap SR, et al. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol. 2011;6(10):2364–2373. doi:10.2215/CJN.02180311
   PubMed Web of Science ®Google Scholar
• Whaley-Connell A, Sowers JR. Obesity and kidney disease: from population to basic science and the search for new therapeutic targets. Kidney Int. 2017;92(2):313–323. doi:10.1016/j.kint.2016.12.034
   PubMed Web of Science ®Google Scholar
• D’Agati VD, Chagnac A, de Vries AP, et al. Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis. Nat Rev Nephrol. 2016;12(8):453–471. doi:10.1038/nrneph.2016.75
   PubMed Web of Science ®Google Scholar
• Xu T, Sheng Z, Yao L. Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment. Front Med. 2017;11(3):340–348. doi:10.1007/s11684-017-0570-3
   PubMed Web of Science ®Google Scholar
• Felizardo RJ, da Silva MB, Aguiar CF, Câmara NO. Obesity in kidney disease: a heavyweight opponent. World J Nephrol. 2014;3(3):50–63. doi:10.5527/wjn.v3.i3.50
   PubMedGoogle Scholar
• Martínez‐Montoro JI, Morales E, Cornejo‐Pareja I, Tinahones FJ, Fernández‐García JC. Obesity-related glomerulopathy: current approaches and future perspectives. Obes Rev. 2022;23(7):e13450. doi:10.1111/obr.13450
   PubMed Web of Science ®Google Scholar
• Wei L, Li Y, Yu Y, et al. Obesity-related glomerulopathy: from mechanism to therapeutic target. Diabetes Metab Syndr Obes. 2021;14:4371–4380. doi:10.2147/DMSO.S334199
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Ruilope LM. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol. 2006;26(3):232–244. doi:10.1159/000093632
   PubMed Web of Science ®Google Scholar
• Suzuki D, Miyata T, Saotome N, et al. Immunohistochemical evidence for an increased oxidative stress and carbonyl modification of proteins in diabetic glomerular lesions. J Am Soc Nephrol. 1999;10(4):822–832. doi:10.1681/ASN.V104822
   PubMed Web of Science ®Google Scholar
• Prabhakar SS. Role of nitric oxide in diabetic nephropathy. Semin Nephrol. 2004;24(4):333–344. doi:10.1016/j.semnephrol.2004.04.005
   PubMed Web of Science ®Google Scholar
• Hall JE, Do Carmo JM, da Silva AA, et al. Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res. 2015;116(6):991–1006. doi:10.1161/CIRCRESAHA.116.305697
   PubMed Web of Science ®Google Scholar
• Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15(11):2792–2800. doi:10.1097/01.ASN.0000141966.69934.21
   PubMed Web of Science ®Google Scholar
• Ellulu MS, Patimah I, Khaza’ai H, et al. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–863. doi:10.5114/aoms.2016.58928
   PubMed Web of Science ®Google Scholar